Company Sequent Scientific Limited

Equities

SEQUENT

INE807F01027

Pharmaceuticals

Market Closed - Bombay S.E. 06:00:48 2024-04-19 am EDT 5-day change 1st Jan Change
119.2 INR -0.13% Intraday chart for Sequent Scientific Limited -3.44% +4.74%

Business Summary

SeQuent Scientific Limited is an India-based animal health company. The Company provides a wide range of animal health products, including finished dose formulations, active pharmaceutical ingredients (APIs), as well as analytical services. The Company operates through the pharmaceuticals segment. The Company is focused on various therapies, such as targeted are anthelmintics (endo and ecto parasiticides), anti-protozoals, nutraceuticals, nonsteroidal anti-inflammatory drugs (NSAIDs), anti-infectives and dermatology. It is specialized in analytical and bio analytical services to support the API, pharmaceutical, personal care and nutraceutical companies. It provides analytical solutions, including method validation, stability, microbiology for APIs and finished products in a variety of dosage forms as per pharmacopoeia monographs, customer developed methods or in-house method development. Its subsidiaries include Alivira Animal Health Limited and SeQuent Research Limited.

Number of employees: 1,301

Sales per Business

INR in Million2022Weight2023Weight Delta
Veterinary Healthcare
100.0 %
14,128 100.0 % 14,209 100.0 % +0.57%

Sales per region

INR in Million2022Weight2023Weight Delta
Europe
40.5 %
5,942 42.1 % 5,755 40.5 % -3.15%
Asia
33.5 %
3,899 27.6 % 4,764 33.5 % +22.16%
Rest of the World
26.0 %
4,286 30.3 % 3,690 26.0 % -13.90%

Managers

Managers TitleAgeSince
Chief Executive Officer 55 22-04-10
Director of Finance/CFO - Nov. 05
Chief Tech/Sci/R&D Officer - 18-12-31
Chief Tech/Sci/R&D Officer - -
Director/Board Member - -
Director/Board Member 57 17-01-07

Members of the board

Members of the board TitleAgeSince
Director/Board Member 55 20-08-16
Chairman 76 20-08-24
Director/Board Member 64 20-08-24
Director/Board Member 56 14-10-27
Director/Board Member 57 17-01-07
Chief Executive Officer 55 22-04-10
Director/Board Member 60 23-08-06
Director/Board Member - 20-11-05
Director/Board Member - 20-12-13
Director/Board Member - -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 249,068,745 114,085,797 ( 45.80 %) 0 45.80 %

Shareholders

NameEquities%Valuation
The Carlyle Group LP (Global Private Equity)
52.79 %
131,680,103 52.79 % 182 M ₹
quant Money Managers Ltd.
4.787 %
11,939,451 4.787 % 17 M ₹
White Oak Capital Partners Pte Ltd.
1.635 %
4,078,604 1.635 % 6 M ₹
The Public Sector Pension Investment Board
1.068 %
2,663,806 1.068 % 4 M ₹
UTI Asset Management Co. Ltd. (Investment Management)
0.2487 %
620,305 0.2487 % 857 541 ₹
Motilal Oswal Asset Management Co. Ltd.
0.0709 %
176,888 0.0709 % 244 539 ₹
ITI Asset Management Ltd. (India)
0.0498 %
124,339 0.0498 % 171 892 ₹
Axis Asset Management Co. Ltd.
0.0144 %
36,000 0.0144 % 49 768 ₹
Dimensional Fund Advisors Ltd.
0.0131 %
32,673 0.0131 % 45 169 ₹
Government of India
0.009181 %
22,900 0.009181 % 31 658 ₹

Company contact information

SeQuent Scientific Ltd.

301/A, Dosti Pinnacle Plot No.E7, Road No. 22, 3rd Floor

400604, Mumbai

+91 22 4111 4777

http://www.sequent.in
address Sequent Scientific Limited(SEQUENT)

Group companies

NameCategory and Sector
Pharmaceuticals: Major
Pharmaceuticals: Major
  1. Stock Market
  2. Equities
  3. SEQUENT Stock
  4. Company Sequent Scientific Limited